Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | X72D2 | IM / LA |
Patient reported the day after receiving vaccine (2/12/25) that She had a temperature of 101 all day associated with a headache. Vaccine injection site was swollen and warm. Patient also reported having pounding headaches on 2/14/25
N/A
Uterine leiomyoma, Fibroid, Glucose intolerance (impaired glucose tolerance), Obesity, Class II, BMI 35-39.9, Metabolic syndrome, Prediabetes, Abnormal uterine bleeding, Thickened endometrium, Hirsutism, HSV-1 (herpes simplex virus 1) infection, Screening for colon cancer, Elevated transaminase level, Pelvic pain
ergocalciferol (VITAMIN D) 1,250 mcg (50,000 unit) Oral Capsule, valACYclovir (VALTREX) 1 gram Oral Tablet
NKA
N/A